Merck is immune from an antitrust lawsuit accusing it of misleading regulators about the effectiveness of its mumps vaccine ...

We recently compiled a list of the 10 Most Undervalued Quality Stocks To Buy According To Analysts. In this article, we will ...

View our latest analysis for Merck Over the last year, we can see that the biggest insider sale was by the Executive VP & President of Merck Animal Health ... free list of small cap stocks ...

Merck faces a class-action lawsuit over alleged misrepresentation of its mumps vaccine potency, claiming anticompetitive ...

Morgan Stanley analyst Terence Flynn has maintained their neutral stance on MRK stock, giving a Hold rating yesterday. Terence Flynn has given ...

Merck is placing a small bet to get a closer look at the two candidates. In return for the upfront payment, Merck has secured the option to license the vaccines for up to $10 million next year.

Merck discontinued two Keytruda late-stage studies. Phase 3 KEYNOTE-867 trial evaluating Keytruda (pembrolizumab) in combination with stereotactic body radiotherapy for stage I or II non-small ...

We recently compiled a list titled 7 Best Cheap Stocks to Buy According to Billionaire Ray Dalio. In this article, we will ...

Our quarterly newsletter’s strategy selects 14 small-cap and large-cap ... vaccines, and animal health products. At its core, Merck is in the business of improving human and animal health ...

We recently compiled a list of 10 Best Quality Stocks to Buy According to Analysts. In this article, we will look at where ...